In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
21 authors.
Murat GünaltılıDepartment of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.ORCID 0000-0001-6116-3936 Esma Kaplan TüzünDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Science, 06010 Ankara, Turkey.
Sura UstaDepartment of Medical Oncology, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Science, 06200 Ankara, Turkey.
Aysun Fatma AkkusDepartment of Medical Oncology, Trakya University School of Medicine, 22030 Edirne, Turkey.ORCID 0000-0003-3922-3845 Selver IşıkDepartment of Medical Oncology, Marmara University School of Medicine, 34899 Istanbul, Turkey.
Caner KaparDepartment of Medical Oncology, Sakarya Training and Research Hospital, 54100 Sakarya, Turkey.ORCID 0000-0002-8879-8533 Serhat SekmekDepartment of Medical Oncology, Amasya Training and Research Hospital, 05100 Amasya, Turkey.ORCID 0000-0003-4650-248X Halil Göksel GüzelDepartment of Medical Oncology, Antalya Training and Research Hospital, 06100 Antalya, Turkey.ORCID 0000-0001-8310-1752 Murad GuliyevDepartment of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.ORCID 0000-0002-2981-8098 Talha OzudogruDepartment of Medical Oncology, Ege University School of Medicine, 35100 Izmir, Turkey.ORCID 0000-0002-5927-8387 Sema Sezin GöksuDepartment of Medical Oncology, Akdeniz University School of Medicine, 07070 Antalya, Turkey.ORCID 0000-0002-1222-0444 Özlem Nuray SeverDepartment of Medical Oncology, Istanbul Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, 34785 Istanbul, Turkey.ORCID 0000-0003-3462-9360 Çagatay ArslanMedical Point Hospital, Izmir University of Economics, 35575 Izmir, Turkey.
Nuri KaradurmuşDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Science, 06010 Ankara, Turkey.
Deniz TuralDepartment of Medical Oncology, Koc University, 34450 Istanbul, Turkey.
Mustafa ÖzgüroğluDepartment of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.ORCID 0000-0002-8417-8628 Emre YekedüzDepartment of Medical Oncology, Ankara University School of Medicine, 06230 Ankara, Turkey.ORCID 0000-0001-6819-5930 Yüksel ÜrünDepartment of Medical Oncology, Ankara University School of Medicine, 06230 Ankara, Turkey.ORCID 0000-0002-9152-9887 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
HALP scoremetastatic renal cell carcinomaoverall survivaltime to treatment failuretyrosine kinase inhibitor
Identifiers
PMID42449669
PMCPMC13359624
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390